Home  >  Pharma People
Pharma People
+ Font Resize -

Bristol-Myers appoints Saurabh Saha, as senior VP, global head of translational medicine

New York
Tuesday, October 10, 2017, 18:00 Hrs  [IST]

Bristol-Myers Squibb Company (BMS) has appointed scientific and business thought-leader, Saurabh Saha, M.D., Ph.D., as senior vice president and global head of translational medicine in the company’s R&D organization, effective.

“Enhancing our translational medicine capability is critical to achieving our mission, and we are excited to add Dr. Saha’s broad leadership experience and deep scientific expertise to our team,” said Tom Lynch, M.D., executive vice president and chief scientific officer of Bristol-Myers Squibb. “Dr. Saha will lead translational research across our therapeutic areas of focus to ensure we have the best understanding of disease and asset-specific biology so we can deliver the right drug to the right patient at the right time.”

Dr. Saha said, “Throughout my career, I have had a passion for developing translational research strategies across disease areas, including oncology and immunology. I look forward to working with Tom and the rest of the R&D organization to advance Bristol-Myers Squibb’s industry-leading pipeline in a way that pushes the boundaries of science and enables us to rapidly deliver innovative medicines to patients with even greater precision.”

Dr. Saha will initially be based at the company’s Waltham, Mass research site until its new state-of-the-art research site in Cambridge, Mass opens in the fourth quarter of 2018.


Post Your commentsPOST YOUR COMMENT
* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |